Feel free to reach out to us via info@quillitinpharma.com
1ScottsRoad,#24-10
ShawCentre,
Singapore228208
UEN No. 201829913M
Quillitin Pharma’s strategy is focused on bringing QPD101 to market via partners with the sales, marketing and distribution infrastructure to maximize the commercial potential from the product. In this respect, Quillitin Pharma is engaged in dialogue with multiple parties, including major pharmaceutical companies, for a launch of products developed within RestoriT Limited (UK), with the initial focus being on markets within the European Union, the United States (subject to regulatory approval) and other selected territories.